BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugano K, Hiroi S, Yamaoka Y. Prevalence of Helicobacter pylori Infection in Asia: Remembrance of Things Past? Gastroenterology 2018;154:257-8. [DOI: 10.1053/j.gastro.2017.08.074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mills JC, Samuelson LC. Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 2018;155:939-44. [PMID: 29964037 DOI: 10.1053/j.gastro.2018.06.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Shah SC, Canakis A, Peek RM Jr, Saumoy M. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States. Clin Gastroenterol Hepatol 2020;18:3026-39. [PMID: 32707341 DOI: 10.1016/j.cgh.2020.07.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Uno Y. Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan. Cancer Med 2019;8:3992-4000. [PMID: 31119891 DOI: 10.1002/cam4.2277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
4 Lin Y, Zheng Y, Wang HL, Wu J. Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030. Gastroenterology 2021;161:116-127.e8. [PMID: 33744306 DOI: 10.1053/j.gastro.2021.03.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ohyama H, Yoshimura D, Hirotsu Y, Amemiya K, Amano H, Miura Y, Ashizawa H, Nakagomi K, Takaoka S, Hosoda K, Suzuki Y, Oyama T, Hada M, Kojima Y, Mochizuki H, Omata M. Rapidly declining trend of signet ring cell cancer of the stomach may parallel the infection rate of Helicobacter pylori. BMC Gastroenterol 2019;19:178. [PMID: 31703565 DOI: 10.1186/s12876-019-1094-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Fagan-Garcia K, Geary J, Chang HJ, McAlpine L, Walker E, Colquhoun A, van Zanten SV, Girgis S, Archie B, Hanley B, Corriveau A, Morse J, Munday R, Goodman KJ; CANHelp Working Group. Burden of disease from Helicobacter pylori infection in western Canadian Arctic communities. BMC Public Health 2019;19:730. [PMID: 31185961 DOI: 10.1186/s12889-019-7065-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sjomina O, Pavlova J, Niv Y, Leja M. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018;23 Suppl 1:e12514. [PMID: 30203587 DOI: 10.1111/hel.12514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 15.7] [Reference Citation Analysis]
8 Tokunaga K, Suzuki C, Hasegawa M, Fujimori I. Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan. Clinicoecon Outcomes Res 2021;13:241-50. [PMID: 33889000 DOI: 10.2147/CEOR.S297680] [Reference Citation Analysis]
9 Myint NPST, Zaw TT, Sain K, Waiyan S, Danta M, Cooper D, Aung NM, Kyi MM, Hanson J. Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability. J Gastroenterol Hepatol 2020;35:617-23. [PMID: 31758571 DOI: 10.1111/jgh.14942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]